Bas J. Verkaik

Bas J. Verkaik

Auto-generated profile, based on publicly available information

Bas J. Verkaik

Amsterdam UMC location University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Meibergdreef 9, Amsterdam, The Netherlands; Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Circulation
Verified
Journal Article
Open access
RSRemy Stieglis
Remy Stieglis
BVBas J. Verkaik
Bas J. Verkaik
HTHanno L. Tan
Hanno L. Tan
RKRudolph W. Koster
Rudolph W. Koster
HSHans van Schuppen
Hans van Schuppen
CWChristian van der Werf
Christian van der Werf
BACKGROUND: In patients with out-of-hospital cardiac arrest who present with an initial shockable rhythm, a longer delay to the first shock decreases the probability of survival, often attributed to cerebral damage. The mechanisms of this decreased survival have not yet been elucidated. Estimating the probability of successful defibrillation and other factors in relation to the time to first shock may guide prehospital care systems to implement policies that improve patient survival by decreasing time to first shock. METHODS: Patients with a witnessed out-of-hospital cardiac arrest and ventricular fibrillation (VF) as an initial rhythm were included using the prospective ARREST registry (Amsterdam Resuscitation Studies). Patient and resuscitation data, including time-synchronized automated external defibrillator and manual defibrillator data, were analyzed to determine VF termination at 5 seconds after the first shock. Delay to first shock was defined as the time from initial emergency call until the first shock by any defibrillator. Outcomes were the proportion of VF termination, return of organized rhythm, and survival to discharge, all in relation to the delay to first shock. A Poisson regression model with robust standard errors was used to estimate the association between delay to first shock and outcomes. RESULTS: Among 3723 patients, the proportion of VF termination declined from 93% when the delay to first shock was 16 minutes ( P trend <0.001). Every additional minute in VF from emergency call was associated with 6% higher probability of failure to terminate VF (adjusted relative risk, 1.06 [95% CI, 1.04–1.07]), 4% lower probability of return of organized rhythm (adjusted relative risk, 0.96 [95% CI, 0.95–0.98]), and 6% lower probability of surviving to discharge (adjusted relative risk, 0.94 [95% CI, 0.93–0.95]). CONCLUSIONS: Every minute of delay to first shock was associated with a significantly lower proportion of VF termination and return of organized rhythm. This may explain the worse outcomes in patients with a long delay to defibrillation. Reducing the time interval from emergency call to first shock to ≤6 minutes could be considered a key performance indicator of the chain of survival.

18 November 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
BVBas J Verkaik
Bas J Verkaik
RWRobert G Walker
Robert G Walker
TTTyson G Taylor
Tyson G Taylor
MEMette M Ekkel
Mette M Ekkel
RMRob Marx
Rob Marx
CWChristian van der Werf
Christian van der Werf
Of patients with out-of-hospital cardiac arrest (OHCA) presenting in ventricular fibrillation (VF), the majority require multiple shocks.1 Guidelines recommend chest compressions be resumed immediately after the shock without a rhythm check.2 In current practice, when VF is present at consecutive rhythm checks, it is uncertain whether previous shocks repeatedly failed to terminate VF (refractory VF) or VF recurred after successful shocks. Alternative defibrillation strategies have been studied in patients found to be in VF at three consecutive rhythm checks.3 We studied the incidence of refractory and recurrent VF in patients receiving multiple consecutive standard shocks and the time to refibrillation in cases with recurrent VF.

8 June 2026 in Resuscitation
Verified
Journal Article
Open access
BVBas J. Verkaik
Bas J. Verkaik
RWRobert G. Walker
Robert G. Walker
TTTyson G. Taylor
Tyson G. Taylor
MEMette M. Ekkel
Mette M. Ekkel
RMRob Marx
Rob Marx
CWChristian van der Werf
Christian van der Werf
In patients with out-of-hospital cardiac arrest (OHCA) who receive multiple shocks, it is often unclear whether they are experiencing refractory or recurrent ventricular fibrillation (VF). Understanding into the cause of refractory VF is limited and the foundational evidence for alternative defibrillation strategies are lacking. To gain further insight into these patients we studied the incidence and possible predictors of refractory VF, and compared outcomes between patients with recurrent VF and those with refractory VF. Using the ARREST registry, we included patients with VF at the first three rhythm checks between 2016 and 2019. ECG waveforms were analysed for successful termination of VF at five seconds after each shock delivered. Patients were classified as having refractory VF if all three shocks failed to terminate VF. The remaining patients were classified as having recurrent VF. Outcomes and possible predictors between both groups were compared. Out of 436 patients who met the inclusion criteria, 22 (5%) had refractory VF and 414 (95%) had recurrent VF. Rates of return of spontaneous circulation (ROSC) and 30-day survival were 9/22 (41%) vs 243/409 (59%) (RR 0.69 [95% CI, 0.41-1.15]) and 5/22 (23%) vs 187/408 (46%) (RR 0.49 [95% CI, 0.23-1.08]) in patients with refractory and recurrent VF, respectively. Predictors for refractory VF were absence of CPR and AED use before emergency medical services arrival, a longer delay to the first shock, and a lower amplitude spectral area value. The small group of refractory VF patients were characterised by unfavourable resuscitation characteristics. Clinical outcomes in refractory VF versus recurrent VF patients remain uncertain due to low patient numbers.

25 October 2025 in Heart Rhythm
Verified
Journal Article
Open access
BVBas J. Verkaik
Bas J. Verkaik
SPSoesja G. Pinto
Soesja G. Pinto
MEMette M. Ekkel
Mette M. Ekkel
HTHanno L. Tan
Hanno L. Tan
HSHans van Schuppen
Hans van Schuppen
MHMichiel Hulleman
Michiel Hulleman

30 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
BVBas J. Verkaik
Bas J. Verkaik
RWRobert G. Walker
Robert G. Walker
TTTyson G. Taylor
Tyson G. Taylor
MEMette Ekkel
Mette Ekkel
RMRob Marx
Rob Marx
CWChristian van der Werf
Christian van der Werf
BackgroundIn patients with out-of-hospital cardiac arrest (OHCA) who receive multiple shocks, it is often unclear whether they are experiencing refractory or recurrent ventricular fibrillation (VF). We studied the incidence and possible predictors of refractory VF, and compared outcomes between patients with recurrent VF and those with refractory VF.MethodsUsing the ARREST registry, we included patients with VF at the first three rhythm checks between 2016 and 2019. ECG waveforms were analysed for successful termination of VF at five seconds after each shock delivered. Patients were classified as having refractory VF if all three shocks failed to terminate VF. The remaining patients were classified as having recurrent VF. Outcomes and possible predictors between both groups were compared.ResultsOut of 436 patients who met the inclusion criteria, 22 (5%) had refractory VF and 414 (95%) had recurrent VF. Rates of return of spontaneous circulation (ROSC) and 30-day survival were 9/22 (41%) vs 243/409 (59%) (RR 0.69 [95% CI, 0.41-1.15]) and 5/22 (23%) vs 187/408 (46%) (RR 0.49 [95% CI, 0.23-1.08]) in patients with refractory and recurrent VF, respectively. Predictors for refractory VF were absence of CPR and AED use before emergency medical services arrival, a longer delay to the first shock, and a lower amplitude spectral area value.ConclusionsThe small group of refractory VF patients were characterised by unfavourable resuscitation characteristics. Patients with refractory VF presumably have lower rates of ROSC and 30-day survival.